Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Alcohol Clin Exp Res. 2022 Feb 17;46(3):477–491. doi: 10.1111/acer.14780

Table 3:

Descriptive Statistics and Bivariate Correlations

% or Mean (SD) 2 3 4 5 6 7 8 9 10
1. Treatment 47% Naltrexone .10** .01 .19* −.10 −.28** −.15 −.30** −.30** −.02
2. Family History 38% Positive -- .12 .08 −.13 .09 .07 .11 .17 .10
3. Sex 69% Male -- .07 −.03 −.23* .09 −.10 .01 .13
4. Medication Dosage 68% Both Pills -- .09** .05* .13** .06* .04 .12**
5. Weekend (day) 58% Weekends -- .22** .19** .18** .18** .09**
6. Drinks Per Day 5.10 (3.48) -- .69** .74** .66** .34**
7. Buzzed SR 4.16 (3.16) -- .83** .70** .41**
8. Drunk SR 2.8 (3.05) -- .87** .37**
9.. Impaired SR 2.25 (2.84) -- .34**
10. Craving 5.83 (1.56) --

Note: Treatment is coded as 1=Naltrexone, 0=Placebo; Family History is coded as 1=positive, 0=negative; Sex is coded as 1=female, 0=male; Medication Dosage is coded as 0=no pill, 1=targeted or daily, 2=targeted and daily; Weekend is coded as 1=weekend, 0=weekday; SR is measured on a scale from 0-10; Craving is measured on a scale from 1 to 9. All within-person variables were group averaged when correlating with other between-level variables.

p < .10

*

p < .05

**

p < .01